摘要
目的 探讨手助腹腔镜下脾切除术的安全性和有效性.方法 回顾性分析2002年7月至2003年12月完成的13例手助腹腔镜下脾切除资料,其中特发性血小板减少性紫癜4例,肝硬化脾亢8例,遗传性球形红细胞增多症1例.结果 13例全部由手助腹腔镜脾切除术完成,无中转开腹,平均手术时间为(2.28±1.31)h,术中平均出血量(165±116)mL,术后住院时间平均5.5天,无并发症发生.结论 手助腹腔镜下脾切除是安全有效的新方法,较适宜于巨脾及周围粘连的脾脏及需附加行门奇断流手术的脾切除.
ObjectiveTo explore the safety and efficacy of HALS. Methods13 patients underwent HALS from 2002.7 to 2003.12 were restrospectively analyzed, there were 4 cases of idiopathic thrombocytopenic (ITP), one case of hereditary spherocytosis (HS) and 8 cases of hypersplenism.ResutsHALS was performed in all patients. No conversion from HALS to open surgery were necessary. The operation time averaged (2.28±1.31)h, and mean blood loss in operaton was(165±116)mL. The media postoperative hospital stay was 5.5 days. All patients recovered smoothly without any postoperative complication. ConclusionHALS is a effective and safe new procedure for patients with splenomegaly,addhesive spleen or for patients who require splenectomy plus portaazygous devascularization.
出处
《科技通报》
北大核心
2004年第4期352-354,共3页
Bulletin of Science and Technology
关键词
手助腹腔镜手术
脾切除术
脾功能亢进
巨脾
hand-assisted laparoscopic surgery
splenectomy
hypersplenism
splenomegaly
